Ivan Pedrosa, M.D., Ph.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Deputy Chair, Strategy and Innovation, Department of Abdominal Imaging, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor (Term tenure), Abdominal Imaging, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2017 | Universidad de Oviedo, Oviedo, ES, Doctor in Philosophy (Ph.D.) |
| 1994 | Universidad Complutense, Madrid, ES, Doctor in Medicine (M.D.) |
Postgraduate Training
| 2021-2025 | Certificate, AI for Senior Executives, Massachusetts Institute of Technology, Boston, MA |
| 2001-2002 | Fellowship, Body MRI, Beth Israel Deaconess Medical Center, Boston, MA |
| 2000-2001 | Fellowship, Trauma, Emergency Radiology, Ryder Trauma Center/University of Miami, Leonard M. Miller School of Medicine, Miami, Florida |
| 1996-2000 | Residency, Radiology, Hospital Clinico San Carlos, University Complutense, Madrid |
| 1995-1995 | Intern, Family Medicine, Hospital Clinico San Carlos, University Complutense, Madrid |
| 1992-1993 | Postgraduate Fellow, Radiology, Research, The University of Texas MD Anderson Cancer Center, Houston, Texas |
Experience & Service
Faculty Academic Appointments
Professor (Tenured) of Radiology, Urology, and Advanced Imaging Research Center, University of Texas Southwestern Medical School, Dallas, Texas, 2017 - 2025
Associate Professor (Tenured) of Radiology, Urology, and Advanced Imaging Research Center, University of Texas Southwestern Medical School, Dallas, Texas, 2011 - 2017
Associate Professor of Radiology, Harvard Medical School, Boston, MA, 2010 - 2011
Assistant Professor of Radiology, Harvard Medical School, Boston, MA, 2005 - 2010
Instructor in Radiology, Harvard Medical School, Boston, MA, 2002 - 2005
Administrative Appointments/Responsibilities
Moderator, Radiological Society of North America, 2024 - Present
Chair, Society for Advanced Body Imaging (SABI), 2024 - Present
Program Chair/Course Organizer, Annual Meeting, Society for Advanced Body Imaging (SABI), 2023 - Present
Vice-Chair Research, Radiology, University of Texas Southwestern, Dallas, Texas, 2023 - 2025
Department Chair (Interim), Radiology, University of Texas Southwestern, Dallas, TX, 2023
Chair/Course Organizer, Radiological Society of North America, 2022 - Present
President-Elect, Board, Society for Advanced Body Imaging (SABI), 2022 - 2023
Chair of Session, American Society of Clinical Oncology, 2022 - Present
Chair/Course Organizer, Radiological Society of North America, 2021 - Present
Vice-President, Board, Society for Advanced Body Imaging (SABI), 2021 - 2022
Metrics for Trials, University of Texas Southwestern, 2021 - Present
Course Director, Society of Abdominal Radiology, 2021 - Present
Vice-Chair Research, Radiology, University of Texas Southwestern, Dallas, Texas, 2019 - 2023
Moderator, Society of Computed Body Tomography & Magnetic Resonance, 2013 - Present
Presiding Officer of Scientific Session, Radiological Society of North America, 2011 - Present
Moderator, Society of Computed Body Tomography & Magnetic Resonance, 2011 - Present
Chief of MRI, Radiology, University of Texas Southwestern, Dallas, Texas, 2011 - 2019
Director, Body MRI Fellowship, Radiology, University of Texas Southwestern, Dallas, Texas, 2011 - 2019
Moderator, Genitourinary Unknown Case Panel, Monthly Meeting, New England Roentgen Ray Society, 2010 - Present
Chief of MRI, Radiology, Beth Israel Deaconess Medical Center, Boston, MA, 2009 - 2011
Director of Body MRI, Radiology, Beth Israel Deaconess Medical Center, Boston, MA, 2008 - 2011
Other Professional Positions
Chair, MR Safety Committee, American College of Radiology (ACR), 2025 - Present
Chair, Kidney Imaging Reporting and Radiology Data System (KIRADS), American College of Radiology (ACR), 2025 - Present
Board Member, SABI Representative, The Academy for Radiology & Biomedical Imaging Research, 2024 - Present
President, Board, Society for Advanced Body Imaging (SABI), 2023 - 2024
Editorial Activities
Ad Hoc Reviewer, Nature Communications, 2025 - Present
Ad Hoc Reviewer, Scientific Reports – Nature, 2017 - Present
Ad Hoc Reviewer, Academic Radiology, 2015 - Present
Ad Hoc Reviewer, Clinical Cancer Research, 2015 - Present
Ad Hoc Reviewer, Clinical Genitourinary Cancer, 2014 - Present
Ad Hoc Reviewer, Journal of Urology, 2013 - Present
Ad Hoc Reviewer, European Radiology, 2012 - Present
Ad Hoc Reviewer, Radiographics, 2012 - Present
Ad Hoc Reviewer, Journal of Magnetic Resonance in Medicine, 2007 - Present
Ad Hoc Reviewer, American Journal of Roentgenology (Journal of the American Roentgen Ray Society), 2005 - Present
Ad Hoc Reviewer, Radiology (Journal of the Radiological Society of North America), 2004 - Present
Selected Publications
Peer-Reviewed Articles
- Mal, A, Xie, B, Gray, Z, Small, C, Ramanand, SG, Gao, Y, Toffessi-Tcheuyap, V, Debnath, S, Christie, A, Miyata, J, Jackson, B, Zhong, H, Gao, B, Lohrey, J, Maalouf, NM, Reddy, S, Minna, J, Pedrosa, I, Sun, X, Mani, RS, Kapur, P, Brugarolas, J. HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma. Cancer discovery 15(12):2485-2504, 2025. e-Pub 2025. PMID: 41065553.
- Wang, X, Keupp, J, Dimitrov, IE, Madhuranthakam, AJ, Udayakumar, D, Taherzadeh, M, Albayrak, E, Moe, OW, Kapur, P, Lenkinski, RE, Pedrosa, I, Vinogradov, E. Evaluation of renal masses with CEST MRI. Magnetic resonance in medicine 94(6):2374-2387, 2025. e-Pub 2025. PMID: 40693363.
- Gao, B, Kanabur, P, Campi, R, Tran, M, Landman, J, Pedrosa, I, Challacombe, B, Wah, TM, Siva, S, Jewett, M, Stewart, GD, Shuch, B, Clayman, RV. ‘BJUI Clinical Dilemma’. BJU international 135(3):371-379, 2025. e-Pub 2025. PMID: 39761985.
- Simchick G, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, do Vale Souza R, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T. J Magn Reson Imaging 61(1):150-165, 2025. e-Pub 2025. PMID: 38662618.
- Buelo CJ, Velikina J, Mao L, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T. Magn Reson Med 93(1):330-340, 2025. e-Pub 2025. PMID: 39238238.
- Khene ZE, Tachibana I, Bertail T, Fleury R, Bhanvadia R, Kapur P, Rajaram S, Guo J, Christie A, Pedrosa I, Lotan Y, Margulis V. Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review. World J Urol 42(1):541, 2024. e-Pub 2024. PMID: 39325194.
- Bezwada D, Perelli L, Lesner NP, Cai L, Brooks B, Wu Z, Vu HS, Sondhi V, Cassidy DL, Kasitinon S, Kelekar S, Cai F, Aurora AB, Patrick M, Leach A, Ghandour R, Zhang Y, Do D, McDaniel P, Sudderth J, Dumesnil D, House S, Rosales T, Poole AM, Lotan Y, Woldu S, Bagrodia A, Meng X, Cadeddu JA, Mishra P, Garcia-Bermudez J, Pedrosa I, Kapur P, Courtney KD, Malloy CR, Genovese G, Margulis V, DeBerardinis RJ. Mitochondrial complex I promotes kidney cancer metastasis. Nature 633(8031):923-931, 2024. e-Pub 2024. PMID: 39143213.
- Vazquez LC, Xi Y, Rasmussen RG, Venzor JER, Kapur P, Zhong H, Dai JC, Morgan TN, Cadeddu JA, Pedrosa I. Characterization of Demographical Histologic Diversity in Small Renal Masses With the Clear Cell Likelihood Score. J Comput Assist Tomogr 48(3):370-377, 2024. e-Pub 2024. PMID: 38213063.
- Wang K, Karalis JD, Elamir A, Bifolco A, Wachsmann M, Capretti G, Spaggiari P, Enrico S, Balasubramanian K, Fatimah N, Pontecorvi G, Nebbia M, Yopp A, Kaza R, Pedrosa I, Zeh H 3rd, Polanco P, Zerbi A, Wang J, Aguilera T, Ligorio M. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients. Ann Surg Oncol 31(4):2608-2620, 2024. e-Pub 2024. PMID: 38151623.
- Prakasam G, Mishra A, Christie A, Miyata J, Carrillo D, Tcheuyap VT, Ye H, Do QN, Wang Y, Reig Torras O, Butti R, Zhong H, Gagan J, Jones KB, Carroll TJ, Modrusan Z, Durinck S, Requena-Komuro MC, Williams NS, Pedrosa I, Wang T, Rakheja D, Kapur P, Brugarolas J. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis. J Clin Invest 134(7), 2024. e-Pub 2024. PMID: 38386415.
- Venishetty N, Taylor J, Xi Y, Howard JM, Ng YS, Wong D, Woldu SL, De Leon AD, Pedrosa I, Margulis V, Bagrodia A. Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor. Clin Genitourin Cancer 22(1):33-37, 2024. e-Pub 2024. PMID: 37468341.
- Guo, J, Goyal, M, Xi, Y, Hinojosa, L, Haddad, G, Albayrak, E, Pedrosa, I. Style Transfer–assisted Deep Learning Method for Kidney Segmentation at Multiphase MRI. Radiology: Artificial Intelligence 5(6), 2023. e-Pub 2023. PMID: 38074795.
- Guo J, Goyal M, Xi Y, Hinojosa L, Haddad G, Albayrak E, Pedrosa I. Style Transfer-assisted Deep Learning Method for Kidney Segmentation at Multiphase MRI. Radiol Artif Intell 5(6):e230043, 2023. e-Pub 2023. PMID: 38074795.
- Hannan R, McLaughlin MF, Pop LM, Pedrosa I, Kapur P, Garant A, Ahn C, Christie A, Zhu J, Wang T, Robles L, Durakoglugil D, Woldu S, Margulis V, Gahan J, Brugarolas J, Timmerman R, Cadeddu J. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. Eur Urol 84(3):275-286, 2023. e-Pub 2023. PMID: 36898872.
- Patel VM, Elias R, Asokan A, Sharma A, Christie A, Pedrosa I, Chiu H, Reznik S, Hannan R, Timmerman R, Brugarolas J. Life-threatening hemoptysis in patients with metastatic kidney cancer. Clin Genitourin Cancer 21(4):497-506, 2023. e-Pub 2023. PMID: 37045713.
- Shen L, Tse JR, Lemieux S, Yoon L, Mullane PC, Liang T, Davenport MS, Pedrosa I, Silverman SG. Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses. Abdom Radiol (NY) 48(8):2636-2648, 2023. e-Pub 2023. PMID: 37202641.
- Bezwada D, Lesner NP, Brooks B, Vu HS, Wu Z, Cai L, Kasitinon S, Kelekar S, Cai F, Aurora AB, Patrick M, Leach A, Ghandour R, Zhang Y, Do D, Sudderth J, Dumesnil D, House S, Rosales T, Poole AM, Lotan Y, Woldu S, Bagrodia A, Meng X, Cadeddu JA, Mishra P, Pedrosa I, Kapur P, Courtney KD, Malloy CR, Margulis V, DeBerardinis RJ. Mitochondrial metabolism in primary and metastatic human kidney cancers. bioRxiv, 2023. e-Pub 2023. PMID: 36798172.
- Hernando D, Zhao R, Yuan Q, Aliyari Ghasabeh M, Ruschke S, Miao X, Karampinos DC, Mao L, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology 306(2):e213256, 2023. e-Pub 2023. PMID: 36194113.
- Costa DN, Meng X, Tverye A, Bagrodia A, Recchimuzzi DZ, Xi Y, Arraj P, Shah RB, Subramanian N, de Leon AD, Roehrborn CG, Rofsky NM, Chen H, Pedrosa I. Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy. J Comput Assist Tomogr 47(1):38-44, 2023. e-Pub 2023. PMID: 35995580.
- Ma Y, Joyce A, Brandenburg O, Saatchi F, Stevens C, Toffessi Tcheuyap V, Christie A, Do QN, Fatunde O, Macchiaroli A, Wong SC, Woolford L, Yousuf Q, Miyata J, Carrillo D, Onabolu O, McKenzie T, Mishra A, Hardy T, He W, Li D, Ivanishev A, Zhang Q, Pedrosa I, Kapur P, Schluep T, Kanner SB, Hamilton J, Brugarolas J. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. Clin Cancer Res 28(24):5405-5418, 2022. e-Pub 2022. PMID: 36190432.
- Hannan R, Christensen M, Christie A, Garant A, Pedrosa I, Robles L, Mannala S, Wang C, Hammers H, Arafat W, Courtney K, Bowman IA, Sher D, Ahn C, Cole S, Choy H, Timmerman R, Brugarolas J. Stereotactic Ablative Radiation for Systemic Therapy-naive Oligometastatic Kidney Cancer. Eur Urol Oncol 5(6):695-703, 2022. e-Pub 2022. PMID: 35985982.
- Kapur P, Zhong H, Araj E, Christie A, Cai Q, Kim D, Miyata J, Tcheuyap VT, Brandenburg O, Carrillo D, Pedrosa I, Brugarolas J, Cadeddu JA. Predicting Oncologic Outcomes in Small Renal Tumors. Eur Urol Oncol 5(6):687-694, 2022. e-Pub 2022. PMID: 36115820.
- Cai Q, Costa DN, Metter CK, Goldberg K, Roehrborn CG, Cadeddu J, Pedrosa I, Meng X, Mostardeiro TR, Shah RB. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology. Urol Oncol 40(10):452.e1-452.e8, 2022. e-Pub 2022. PMID: 36008255.
- Freifeld Y, Pedrosa I, Mclaughlin M, Correa RM, Louie AV, Maldonado JA, Tang C, Kadow B, Kutikov A, Uzzo RG, Porta C, Bucknell NW, Siva S, Brugarolas J, Margulis V, Timmerman R, Hannan R. Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Urol Oncol 40(4):166.e9-166.e13, 2022. e-Pub 2022. PMID: 35144866.
- Kapur P, Gao M, Zhong H, Chintalapati S, Mitui M, Barnes SD, Zhou Q, Miyata J, Carrillo D, Malladi VS, Rakheja D, Pedrosa I, Xu L, Kinch L, Brugarolas J. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Mod Pathol 35(3):333-343, 2022. e-Pub 2022. PMID: 34538873.
- Huang J, Guo J, Pedrosa I, Fei B. Deep Learning-based Deformable Registration of Dynamic Contrast-Enhanced MR Images of the Kidney. Proc SPIE Int Soc Opt Eng 12034, 2022. e-Pub 2022. PMID: 36793654.
- Rasmussen RG, Xi Y, Sibley RC 3rd, Lee CJ, Cadeddu JA, Pedrosa I. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance. AJR Am J Roentgenol 218(1):101-110, 2022. e-Pub 2022. PMID: 34286596.
- Guo J, Odu A, Pedrosa I. Deep learning kidney segmentation with very limited training data using a cascaded convolution neural network. PLoS One 17(5):e0267753, 2022. e-Pub 2022. PMID: 35533181.
- Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res 27(24):6716-6725, 2021. e-Pub 2021. PMID: 34551906.
- Elias R, Tcheuyap VT, Kaushik AK, Singla N, Gao M, Reig Torras O, Christie A, Mulgaonkar A, Woolford L, Stevens C, Kettimuthu KP, Pavia-Jimenez A, Boroughs LK, Joyce A, Dakanali M, Notgrass H, Margulis V, Cadeddu JA, Pedrosa I, Williams NS, Sun X, DeBerardinis RJ, Oz OK, Zhong H, Seshagiri S, Modrusan Z, Cantarel BL, Kapur P, Brugarolas J. A renal cell carcinoma tumorgraft platform to advance precision medicine. Cell Rep 37(8):110055, 2021. e-Pub 2021. PMID: 34818533.
- Kim K, Zhou Q, Christie A, Stevens C, Ma Y, Onabolu O, Chintalapati S, Mckenzie T, Tcheuyap VT, Woolford L, Zhang H, Singla N, Parida PK, Marquez-Palencia M, Pedrosa I, Margulis V, Sagalowsky A, Xie Z, Wang T, Durinck S, Modrusan Z, Seshagiri S, Kapur P, Brugarolas J, Malladi S. Determinants of renal cell carcinoma invasion and metastatic competence. Nat Commun 12(1):5760, 2021. e-Pub 2021. PMID: 34608135.
- Udayakumar D, Zhang Z, Xi Y, Dwivedi DK, Fulkerson M, Haldeman S, McKenzie T, Yousuf Q, Joyce A, Hajibeigi A, Notgrass H, de Leon AD, Yuan Q, Lewis MA, Madhuranthakam AJ, Sibley RC, Elias R, Guo J, Christie A, McKay RM, Cadeddu JA, Bagrodia A, Margulis V, Brugarolas J, Wang T, Kapur P, Pedrosa I. Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform. Clin Cancer Res 27(17):4794-4806, 2021. e-Pub 2021. PMID: 34210685.
- Smith WC, Khatri G, Dunn SH, Zeidan N, Browning TG, Kubiliun N, Mansour JC, Minter RM, Vu L, Coleman VL, Pedrosa I, Leyendecker JR. Facilitating Surveillance of Incidental Findings Using a Novel Reporting Template: Proof of Concept in Patients With Pancreatic Abnormalities. J Am Coll Radiol 18(9):1246-1257, 2021. e-Pub 2021. PMID: 34283988.
- Wang X, Udayakumar D, Xi Y, Rofsky NM, Pedrosa I, Madhuranthakam AJ. Single-shot RARE with Dixon: Application to robust abdominal imaging with uniform fat and water separation at 3T. Magn Reson Med 86(3):1463-1471, 2021. e-Pub 2021. PMID: 33929055.
- Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R. Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial. Int J Radiat Oncol Biol Phys 110(4):1135-1142, 2021. e-Pub 2021. PMID: 33549705.
- Kapur P, Gao M, Zhong H, Rakheja D, Cai Q, Pedrosa I, Margulis V, Xu L, Kinch L, Brugarolas J. Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss. Adv Anat Pathol 28(4):251-257, 2021. e-Pub 2021. PMID: 34009776.
- Subramanian N, Recchimuzzi DZ, Xi Y, Diaz de Leon A, Chen H, Xie D, Goldberg K, Rofsky NM, Pedrosa I, Costa DN. Impact of the Number of Cores on the Prostate Cancer Detection Rate in Men Undergoing in-Bore Magnetic Resonance Imaging-Guided Targeted Biopsies. J Comput Assist Tomogr 45(2):203-209, 2021. e-Pub 2021. PMID: 33273160.
- Costa DN, Cai Q, Xi Y, Recchimuzzi DZ, Subramanian N, Bagrodia A, Rofsky NM, Roehrborn CG, Hornberger B, Shah RB, Goldberg K, Diaz de Leon A, Pedrosa I. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies. Radiol Imaging Cancer 3(2):e200123, 2021. e-Pub 2021. PMID: 33817652.
- Tsai LL, Bhatt RS, Strob MF, Jegede OA, Sun MRM, Alsop DC, Catalano P, McDermott D, Robson PM, Atkins MB, Pedrosa I. Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma. Radiology 298(2):332-340, 2021. e-Pub 2021. PMID: 33258745.
- Dwivedi DK, Xi Y, Kapur P, Madhuranthakam AJ, Lewis MA, Udayakumar D, Rasmussen R, Yuan Q, Bagrodia A, Margulis V, Fulkerson M, Brugarolas J, Cadeddu JA, Pedrosa I. Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. Clin Genitourin Cancer 19(1):12-21.e1, 2021. e-Pub 2021. PMID: 32669212.
- Gerber DE, Putnam WC, Fattah FJ, Kernstine KH, Brekken RA, Pedrosa I, Skelton R, Saltarski JM, Lenkinski RE, Leff RD, Ahn C, Padmanabhan C, Chembukar V, Kasiri S, Kallem RR, Subramaniyan I, Yuan Q, Do QN, Xi Y, Reznik SI, Pelosof L, Faubert B, DeBerardinis RJ, Kim J. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer. Clin Cancer Res 26(22):6017-6027, 2020. e-Pub 2020. PMID: 32847935.
- Patel V, Elias R, Formella J, Schwartzman W, Christie A, Cai Q, Malladi V, Kapur P, Vazquez M, McKay R, Pedrosa I, Hannan R, Hammers H, Brugarolas J. Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33139246.
- Pirasteh A, Johnson B, Dimitrov IE, Costa DN, Diaz de Leon A, Xi Y, Madhuranthakam AJ, Pedrosa I. Turbo Spin-Echo Diffusion-Weighted Imaging in Prostate Magnetic Resonance Imaging of Men With Pelvic Hardware. J Comput Assist Tomogr 44(4):519-526, 2020. e-Pub 2020. PMID: 32697522.
- Singla N, Xie Z, Zhang Z, Gao M, Yousuf Q, Onabolu O, McKenzie T, Tcheuyap VT, Ma Y, Choi J, McKay R, Christie A, Torras OR, Bowman IA, Margulis V, Pedrosa I, Przybycin C, Wang T, Kapur P, Rini B, Brugarolas J. Pancreatic tropism of metastatic renal cell carcinoma. JCI Insight 5(7), 2020. e-Pub 2020. PMID: 32271170.
- Courtney KD, Ma Y, Diaz de Leon A, Christie A, Xie Z, Woolford L, Singla N, Joyce A, Hill H, Madhuranthakam AJ, Yuan Q, Xi Y, Zhang Y, Chang J, Fatunde O, Arriaga Y, Frankel AE, Kalva S, Zhang S, McKenzie T, Reig Torras O, Figlin RA, Rini BI, McKay RM, Kapur P, Wang T, Pedrosa I, Brugarolas J. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma. Clin Cancer Res 26(4):793-803, 2020. e-Pub 2020. PMID: 31727677.
- Yokoo T, Singal AG, Diaz de Leon A, Ananthakrishnan L, Fetzer DT, Pedrosa I, Khatri G. Prevalence and clinical significance of discordant LI-RADS((R)) observations on multiphase contrast-enhanced MRI in patients with cirrhosis. Abdom Radiol (NY) 45(1):177-187, 2020. e-Pub 2020. PMID: 31342103.
- Cai Q, Christie A, Rajaram S, Zhou Q, Araj E, Chintalapati S, Cadeddu J, Margulis V, Pedrosa I, Rakheja D, McKay RM, Brugarolas J, Kapur P. Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type. EBioMedicine 51:102526, 2020. e-Pub 2020. PMID: 31859241.
Review Articles
- Su, S, Yadu, N, Khatri, G, Khasawneh, H, Pedrosa, I, Yokoo, T. An algorithmic approach to MR characterization of focal liver lesions in adults without cirrhosis. European Journal of Radiology 185, 2025. e-Pub 2025. PMID: 39978238.
- Silverman, SG, Pedrosa, I, Schieda, N, Margulis, V, Kapur, P, Davenport, MS. In Pursuit of KI-RADS. Radiology 314(3), 2025. e-Pub 2025. PMID: 40100027.
- Vinogradov, E, Keupp, J, Dimitrov, IE, Seiler, S, Pedrosa, I. CEST-MRI for body oncologic imaging. NMR in Biomedicine 36(6), 2023. e-Pub 2023. PMID: 36640112.
Other Articles
- McGrath TA, Davenport MS, Silverman SG, Lim CS, Almalki YE, Arita Y, Bai X, Basha MAA, Dana J, Elbanna KY, Kamaya A, Jeyaraj SK, Park KJ, Park MY, Reinhold C, Tse JR, Wang H, Pedrosa I, Schieda N Bosniak Classification of Cystic Renal Masses Version 2019: Proportion of Malignancy by Class and Subclass-Systematic Review and Meta-Analysis. AJR Am J Roentgenol 224(3):e2432342, 2025. PMID: 39772585.
- Pedrosa, I MRI Clear Cell Likelihood Score for Indeterminate Solid Renal Masses. Radiographics 43(7), 2023. PMID: 37319027.
- Schieda N, Davenport MS, Silverman SG, Bagga B, Barkmeier D, Blank Z, Curci NE, Doshi AM, Downey RT, Edney E, Granader E, Gujrathi I, Hibbert RM, Hindman N, Walsh C, Ramsay T, Shinagare AB, Pedrosa I Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses. Radiology 306(3):e239001, 2023. PMID: 36803006.
- Sharma, A, Elias, R, Christie, A, Williams, NS, Pedrosa, I, Bjarnason, G, Brugarolas, J Erratum. Kidney Cancer 7(1):15, 2023. PMID: 36999139.
- Schieda N, Davenport MS, Krishna S, Edney EA, Pedrosa I, Hindman N, Baroni RH, Curci NE, Shinagare A, Silverman SG Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. Radiographics 42(1):E33, 2022. PMID: 34990332.
Patient Reviews
CV information above last modified July 22, 2026